LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia

LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia

To evaluate the addition of ezetimibe or placebo to on-going simvastatin treatment on attaining the LDL-C treatment target of 2.60 mmol/L and 100 mg/dL and

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current medical research and opinion 2005-04, Vol.21 (4), p.571-578
Hauptverfasser: Brohet, C, Banai, S, Alings, A M W, Massaad, R, Davies, M J, Allen, C
Format: Artikel
Sprache:eng
Schlagworte:
Administration, Oral
Aged
Anticholesteremic Agents - therapeutic use
Azetidines - therapeutic use
Cholesterol, LDL - blood
Cholesterol, LDL - drug effects
Coronary Disease - complications
Double-Blind Method
Drug Therapy, Combination
Ezetimibe
Female
Humans
Hypercholesterolemia - drug therapy
Male
Middle Aged
Placebos
Simvastatin - therapeutic use
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To evaluate the addition of ezetimibe or placebo to on-going simvastatin treatment on attaining the LDL-C treatment target of 2.60 mmol/L and 100 mg/dL and
ISSN:0300-7995
DOI:10.1185/030079905X382004